查看購物車
  • Simplified Chinese
  • English
  • Japanese
罕見病醫療食品市場規模,份額和趨勢分析報告：按給藥途徑,產品,應用（酪氨酸血症,MSUD,同型半胱氨酸尿症）,銷售渠道,地區,細分市場預測2023~2030
市場調查報告書
商品編碼
1170897

罕見病醫療食品市場規模,份額和趨勢分析報告：按給藥途徑,產品,應用（酪氨酸血症,MSUD,同型半胱氨酸尿症）,銷售渠道,地區,細分市場預測2023~2030

Medical Foods For Orphan Diseases Market Size, Share & Trends Analysis Report By Route Of Administration, By Product, By Application (Tyrosinemia, MSUD, Homocystinuria), By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

罕見病醫療食品市場的增長和趨勢

到 2030 年，全球罕見病醫療食品市場預計將達到 19 億美元。 根據 Grandview Research 的一份新報告，預計從 2022 年到 2030 年，它的複合年增長率將達到 5.5%。 促進該行業增長的主要因素是罕見病患病率上升以及人們對此類罕見病的認識不斷提高。 此外，政府加大早期篩查力度，主要參與者加大力度開發產品以滿足此類利基細分市場，也預示著良好的增長前景。

各種罕見疾病需要特殊的醫學營養來預防嚴重殘疾並使兒童和成人能夠正常成長。 由食物蛋白質引起的楓糖漿尿病和短腸綜合症等疾病需要特殊飲食以保持健康。 對這些罕見疾病的認識不斷提高以及飲食治療的有效性不斷提高，預計將提供進一步的增長途徑。

醫療食品價格昂貴，可能會或可能不會被健康保險覆蓋。 由於 FDA 未將藥用食品歸類為藥物，因此許多保險計劃不涵蓋藥用食品。 這可能會阻礙預測期內的市場擴張。

與其他行業不同，COVID-19 對市場增長產生了積極影響。 免疫和健康食品意識的提高導致臨床食品的採用率顯著提高。 與 2019 年相比，2020 年消費者選擇了更健康的飲食，包括營養支持和飲食。

到 2022 年，口腔部分以超過 69.5% 的收入份額佔據市場主導地位。 藥物食品的口服途徑仍然是最方便和無憂的。 因此，它仍然是全球消費者最喜歡的途徑，而且口服產品很容易買到。 擴大片劑、粉劑和增稠劑等形式的口服產品的生產也仍然是增長的主要驅動力。

到 2022 年，粉末業務將佔最大的收入份額，超過 35.4%。 粉狀藥用食品的現成商業可用性一直是該細分市場增長的主要因素。 此外，易於使用的粉狀產品受到患有各種罕見疾病的兒科和老年患者的廣泛青睞，這繼續推動了這一細分市場的擴張。

2022 年，設施銷售渠道的收入份額最大，超過 41.2%。 這部分包括家庭護理場所、醫院和殘疾人設施。 預計在線銷售部門將在預測期內以最快的速度擴張。 由於這些銷售渠道提供的便利，越來越多的人選擇在線購買藥用食品。

罕見病醫療食品市場報告要點

2022 年的市場規模為 12 億美元，預計 2022 年至 2030 年的複合年增長率為 5.5%。 罕見病患病率上升、醫療費用、早期篩查和對罕見病的認識是推動增長的關鍵因素

到 2022 年，口腔部分將佔總銷售額的 69.5% 以上。 然而，腸內給藥領域預計在預測期內增長最快。 主要參與者高度關注技術先進的腸內餵養設備的開發，預計這些設備將在這一領域的增長中發揮重要作用。

2022 年，粉末業務的收入份額最大，超過 35.4%。 然而，預計液體部分將在預測期內以最快的複合年增長率增長。 由於有限或無法消費固體製劑，兒科和老年消費者越來越多地採用液體製劑是推動這一細分市場增長的主要原因。

到 2022 年，機構銷售渠道將佔最大收入份額，超過 41.2%。 越來越多的患者前往醫院和其他醫療中心診斷和治療各種罕見病，繼續推動這一細分市場的增長

其他部門在 2022 年的收入份額最大，超過 36.5%。 越來越多的低過敏性產品的商業推出以及各種配方的此類產品的商業可用性進一步推動了這一細分市場的增長。 然而，預計 FPIES 州將在預測期內表現出最快的複合年增長率

2022 年，北美收入佔比最大，超過 30.6%。 在預測期內，亞太地區預計將成為增長最快的區域市場。 滲透率的提高、意識的提高、醫療食品使用的增加以及政府的幾項重大舉措繼續支撐著增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
  • 調查方法
    • 信息採購
      • 購買的數據庫
      • GVR 內部數據庫
    • 初步調查：
  • 調查範圍和假設
  • 列表到數據源

第 2 章執行摘要

  • 市場展望
  • 細分市場展望
  • 競爭考慮
  • 全球罕見病醫療食品概覽

第 3 章全球罕見病醫療食品市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司的市場前景
    • 相關/子公司市場前景
  • 描繪滲透率和增長前景
  • 價格分析
  • 用戶視角分析
    • 消費者行為分析
    • 市場影響者分析
  • 技術展望
    • 技術時間表
  • 監管框架
    • 報銷框架
    • 標準與合規性
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
    • 行業問題
  • 罕見病醫療食品市場分析工具
    • 行業分析 - 搬運工
      • 供應商的力量
      • 買家的議價能力
      • 替代威脅
      • 來自新進入者的威脅
      • 競爭公司之間的敵對關係
    • PESTEL 分析
      • 政治形勢
      • 環境狀況
      • 社交情況
      • 技術概況
      • 法律狀況
      • 經濟狀況
    • 對主要交易和戰略聯盟的分析
      • 併購
      • 許可和合作夥伴關係
    • 市場進入策略
  • COVID-19 對市場的影響

第4章罕見病醫療食品市場競爭分析

  • 主要市場進入者的近期趨勢和影響分析
  • 競爭分類法
  • 公司市場分析
  • 主要公司的市場份額分析 (%)

第 5 章罕見病醫療食品市場：給藥途徑的估計和趨勢分析

  • 定義和範圍
  • 全球罕見病醫療食品市場：給藥途徑市場份額分析，2022 年和 2030 年
  • 口語
  • 腸內

第 6 章罕見病醫療食品市場：產品預測和趨勢分析

  • 定義和範圍
  • 全球罕見病醫療食品市場：產品市場份額分析，2022 年和 2030 年
  • 藥丸
  • 粉末
  • 液體
  • 其他

第7章罕見病醫療食品市場：應用預估及趨勢分析

  • 定義和範圍
  • 全球罕見病醫療食品市場：應用市場份額分析，2022 年和 2030 年
  • 苯丙酮尿症
  • 嗜酸性粒細胞性食管炎
  • 狂歡
  • 酪氨酸血症
  • 密歇根大學
  • 同型半胱氨酸尿症
  • 其他

第 8 章罕見病醫療食品市場：銷售渠道估計和趨勢分析

  • 定義和範圍
  • 全球罕見病醫療食品市場：2022 年和 2030 年分銷渠道市場份額分析
  • 在線銷售
  • 機構銷售
  • 零售銷售

第 9 章罕見病醫療食品市場：按地區、給藥途徑、產品、應用和銷售渠道分類的估計和趨勢分析

  • 全球罕見病醫療食品市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 俄羅斯
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 新西蘭
    • 新加坡
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第十章公司簡介

  • DANONE
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • NESTLE
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • ABBOTT
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • MEAD JOHNSON &COMPANY, LLC
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Relief Therapeutics
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Solace Nutrition
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Ajinomoto Cambrooke, Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
Product Code: GVR-4-68039-993-4

Medical Foods For Orphan Diseases Market Growth & Trends:

The global medical foods for orphan diseases market size is expected to reach USD 1.9 billion by 2030. It is expected to expand at a CAGR of 5.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to the industry's growth are the growing prevalence of orphan diseases and increasing awareness about such rare conditions. Moreover, rising government initiatives for early screening and increasing initiatives by key players to develop products that cater to such niche segments also spell a promising horizon of growth.

Special medical nutritional requirements are needed for a variety of rare diseases in order to prevent major disabilities and allow normal growth in children and adults. Conditions like food protein-induced maple syrup urine disease, short bowel syndrome, and others, require special dietary requirements in order to maintain robust health. The growing awareness of such rare conditions and increased efficacy of diet plans also promise more avenues for growth.

Medical foods are expensive and may or may not be covered under health insurance. Since the FDA does not classify medicinal foods as drugs, many insurance plans do not cover them. This can impede market expansion over the forecast period.

Unlike other industries, COVID-19 had a positive impact on market growth. The increased awareness about immunity and healthy foods led to a significant rise in the adoption rate of clinical foods. In the year 2020, consumers opted for much healthier diets encompassing nutritional support and dietetic care as compared to the year 2019.

The oral segment dominated the market with a revenue share of over 69.5% in 2022. The oral route for medicinal foods remains the most convenient, and hassle-free. Hence, it remains the most preferred route for consumers globally and oral products are easily available. The expanding production of oral goods in the form of tablets, powder, and pre-thickened products also remains a prominent driver of growth.

The powder segment accounted for the largest revenue share of over 35.4% in 2022. Easy commercial availability of medicinal foods in powdered form is largely responsible for the segment's expansion. Additionally, powered forms of products are simple to use and hence widely preferred by pediatric and geriatric patients suffering from various rare diseases, which continues to drive the segment's expansion.

The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The segment includes home care settings, hospitals, and disability facilities. The online sales segment is anticipated to expand at the fastest rate over the forecast period. Due to the convenience, these sales channel provides, more people choose to buy medicinal foods online.

Medical Foods For Orphan Diseases Market Report Highlights:

  • The market size was valued at USD 1.2 billion in 2022 and is expected to grow at a CAGR of 5.5% from 2022 to 2030. Increasing prevalence of rare diseases, healthcare expenditure, early screening, and awareness about rare diseases are some key factors that propel the growth
  • The oral segment held the dominant revenue share of over 69.5% in 2022. However, the enteral route of the administration segment is expected to showcase the fastest growth over the forecast years. Key players are highly focused on developing technologically advanced enteral feeding devices which are anticipated to play a major role in this segment's growth.
  • The powder segment accounted for the largest revenue share of over 35.4% in 2022. However, the liquid segment is expected to grow at the fastest CAGR over the forecast period. The rising adoption rate of liquid formulations by pediatric and geriatric consumers, as the intake of solid formulations is restricted or unfeasible is the major reason that fuels the segment's growth
  • The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The increasing number of patient visits to hospitals and other healthcare centers for the diagnosis and treatment of different orphan disorders continues to propel the growth of the segment
  • The others segment accounted for the largest revenue share of over 36.5% in 2022. The increasing number of hypoallergenic product launches and easy commercial availability of such products in various formulations further boost the segment's growth. However, FPIES condition is expected to showcase the fastest CAGR over the forecast period
  • In 2022, North America held the largest revenue share of over 30.6%. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Increasing penetration rate, awareness, growing use of medical foods, and several key government initiatives remain the cornerstone of its growth

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR's internal database
    • 1.3.2 Primary Research:
  • 1.4 Research Scope and Assumptions
  • 1.5 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Global Medical Foods for Orphan Diseases Snapshot

Chapter 3 Global Medical Foods for Orphan Diseases Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Pricing Analysis
  • 3.4 User Perspective Analysis
    • 3.4.1 Consumer behavior analysis
    • 3.4.2 Market influencer analysis
  • 3.5 Technology Outlook
    • 3.5.1 Technology timeline
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement framework
    • 3.6.2 Standards and compliances
  • 3.7 Market Dynamics
    • 3.7.1 Market driver analysis
    • 3.7.2 Market restraint analysis
    • 3.7.3. Industry Challenges
  • 3.8 Medical Foods for Orphan Diseases Market Analysis Tools
    • 3.8.1. Industry Analysis - Porter's
      • 3.8.1.1 Supplier power
      • 3.8.1.2 Buyer power
      • 3.8.1.3 Substitution threat
      • 3.8.1.4 Threat from new entrant
      • 3.8.1.5 Competitive rivalry
    • 3.8.2. PESTEL analysis
      • 3.8.2.1 Political landscape
      • 3.8.2.2 Environmental landscape
      • 3.8.2.3 Social landscape
      • 3.8.2.4 Technology landscape
      • 3.8.2.5 Legal landscape
      • 3.8.2.6 Economic landscape
    • 3.8.3 Major deals & strategic alliances analysis
      • 3.8.3.1 Mergers & acquisitions
      • 3.8.3.2 Licensing & partnership
    • 3.8.4 Market entry strategies
  • 3.9 COVID-19 Impact on the market

Chapter 4 Medical Foods for Orphan Diseases Market-Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 4.2 Competition Categorization
  • 4.3 Company Market Position Analysis
  • 4.4 Key Company Market Share Analysis (%)

Chapter 5 Medical Foods for Orphan Diseases Market: Route of Administration Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Global Medical Foods for Orphan Diseases Market: Route of Administration Market Share Analysis, 2022 and 2030
  • 5.3 Oral
    • 5.3.1 Oral market estimates and forecasts, 2016 - 2030 (USD Million)
  • 5.4 Enteral
    • 5.4.1 Enteral market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 6 Medical Foods for Orphan Diseases Market: Product Estimates & Trend Analysis

  • 6.1 Definitions & Scope
  • 6.2 Global Medical Foods for Orphan Diseases Market: Product Market Share Analysis, 2022 and 2030
  • 6.3 Pills
    • 6.3.1 Pills market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.4 Powders
    • 6.4.1 Powders market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.5 Liquid
    • 6.5.1 Liquid market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 7 Medical Foods for Orphan Diseases Market: Application Estimates & Trend Analysis

  • 7.1 Definitions & Scope
  • 7.2 Global Medical Foods for Orphan Diseases Market: Application Market Share Analysis, 2022 and 2030
  • 7.3 Phenylketonuria
    • 7.3.1 Phenylketonuria market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.4 Eosinophilic Esophagitis
    • 7.4.1 Eosinophilic Esophagitis market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.5 FPIES
    • 7.5.1 FPIES market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.6 Tyrosinemia
    • 7.6.1 Tyrosinemia market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.7 MSUD
    • 7.7.1 MSUD market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.8 Homocystinuria
    • 7.8.1 Homocystinuria market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 8 Medical Foods for Orphan Diseases Market: Sales Channel Estimates & Trend Analysis

  • 8.1 Definitions & Scope
  • 8.2 Global Medical Foods for Orphan Diseases Market: Sales Channel Market Share Analysis, 2022 and 2030
  • 8.3 Online sales
    • 8.3.1 Online sales market estimates and forecasts, 2016 - 2030 (USD Million)
  • 8.4 Institutional sales
    • 8.4.1 Institutional sales market estimates and forecasts, 2016 - 2030 (USD Million)
  • 8.5 Retail sales
    • 8.5.1 Retail sales market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 9 Medical Foods for Orphan Diseases Market: Regional Estimates & Trend Analysis, By Route of Administration, Product, Application, and Sales Channel

  • 9.1 Global Medical Foods for Orphan Diseases Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.2 U.K.
      • 9.3.2.1 U.K. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.3 Germany
      • 9.3.3.1 Germany medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.5 Spain
      • 9.3.5.1 Spain medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.6 Italy
      • 9.3.6.1 Italy medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.7 Russia
      • 9.3.7.1 Russia medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia pacific medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.3 Japan
      • 9.4.3.1 Japan medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.5 Australia
      • 9.4.5.1 Australia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.6 New Zealand
      • 9.4.6.1 New Zealand medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.7 Singapore
      • 9.4.7.1 Singapore medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.8 South Korea
      • 9.4.8.1 South Korea medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.4 Argentina
      • 9.5.4.1 Argentina medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.6 MEA
    • 9.6.1 MEA medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 UAE medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)

Chapter 10 Company Profiles

  • 10.1 DANONE
    • 10.1.1 Company overview
    • 10.1.2 Financial performance
    • 10.1.3 Product benchmarking
    • 10.1.4 Strategic initiatives
  • 10.2 NESTLE
    • 10.2.1 Company overview
    • 10.2.2 Financial performance
    • 10.2.3 Product benchmarking
    • 10.2.4 Strategic initiatives
  • 10.3 ABBOTT
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 MEAD JOHNSON & COMPANY, LLC
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 Relief Therapeutics
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Solace Nutrition
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Ajinomoto Cambrooke, Inc.
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies, /technology disruptors/innovators
  • Table 3 Few examples of the medical foods in the oral form
  • Table 4 Few examples of the products available in powder form
  • Table 5 Few examples of medical foods in the other formulations
  • Table 6 Oral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
  • Table 7 Enteral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
  • Table 8 North America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 9 North America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 10 North America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 11 North America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 12 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 13 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 14 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 15 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 16 Canada medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 17 Canada medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 18 Canada medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 19 Canada medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 20 Europe medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 21 Europe medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 22 Europe medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 23 Europe medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 24 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 25 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 26 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 27 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 28 Germany medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 29 Germany medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 30 Germany medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 31 Germany medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 32 France medical foods for orphan diseases market revenue estimates and forecast, by route of administration, 2016 - 2030 (USD Million)
  • Table 33 France medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 34 France medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 35 France medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 36 Spain medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 37 Spain medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 38 Spain medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 39 Spain medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 40 Italy medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 41 Italy medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 42 Italy medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 43 Italy medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 44 Russia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 45 Russia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 46 Russia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 47 Russia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 48 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 49 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 50 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 51 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 52 Japan medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 53 Japan medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 54 Japan medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 55 Japan medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 56 China medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 57 China medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 58 China medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 59 China medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 60 Australia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 61 Australia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 62 Australia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 63 Australia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 64 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 65 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 66 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 67 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 68 India medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 69 India medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 70 India medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 71 India medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 72 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 73 South Korea medical foods for orphan diseases market revenue estimates and forecast, by product, 2016 - 2030 (USD Million)
  • Table 74 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 75 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 76 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 77 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 78 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 79 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 80 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 81 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 82 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 83 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 84 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 85 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 86 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 87 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 88 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 89 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 90 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 91 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 92 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 93 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 94 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 95 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 96 MEA medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 97 MEA medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 98 MEA medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 99 MEA medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 100 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 101 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 102 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 103 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 104 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 105 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 106 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 107 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 108 UAE medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 109 UAE medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 110 UAE medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 111 UAE medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 112 List of other players

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Medical foods for orphan diseases market snapshot, 2022 (USD Million)
  • Fig. 5 Medical foods for orphan diseases market dynamics
  • Fig. 6 Medical foods for orphan diseases market segmentation
  • Fig. 7 Penetration & growth prospects mapping
  • Fig. 8 Technology timeline
  • Fig. 9 Medical foods for orphan diseases market driver impact
  • Fig. 10 Medical foods for orphan diseases market restraints impact
  • Fig. 11 Competition categorization
  • Fig. 12 Key company market share analysis (%)
  • Fig. 13 Company market position analysis
  • Fig. 16 Medical foods for orphan diseases market: Route of administration market share analysis, 2022
  • Fig. 17 Segment Dashboard
  • Fig. 18 Oral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 19 Enteral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 20 Medical foods for orphan diseases market: Product market share analysis, 2022
  • Fig. 21 Segment Dashboard
  • Fig. 22 Medical foods for orphan diseases market estimates and forecasts for pills formulation, 2016 - 2030 (USD Million)
  • Fig. 23 Medical foods for orphan diseases market estimates and forecasts for powder formulation, 2016 - 2030 (USD Million)
  • Fig. 24 Medical foods for orphan diseases market estimates and forecasts for liquid formulation, 2016 - 2030 (USD Million)
  • Fig. 25 Medical foods for orphan diseases market estimates and forecasts for other formulations, 2016 - 2030 (USD Million)
  • Fig. 26 Medical foods for orphan diseases market: Application market share analysis, 2022
  • Fig. 27 Segment Dashboard
  • Fig. 29 Medical foods for orphan diseases market estimates and forecasts for phenylketonuria, 2016 - 2030 (USD Million)
  • Fig. 30 Medical foods for orphan diseases market estimates and forecasts for eosinophilic esophagitis, 2016 - 2030 (USD Million)
  • Fig. 31 Medical foods for orphan diseases market estimates and forecasts for FPIES, 2016 - 2030 (USD Million)
  • Fig. 32 Medical foods for orphan diseases market estimates and forecasts for MSUD, 2016 - 2030 (USD Million)
  • Fig. 33 Medical foods for orphan diseases market estimates and forecasts for Homocystinuria, 2016 - 2030 (USD Million)
  • Fig. 34 Medical foods for orphan diseases market estimates and forecasts for other diseases, 2016 - 2030 (USD Million)
  • Fig. 35 Medical foods for orphan diseases market: Sales channel market share analysis, 2022
  • Fig. 36 Medical foods for orphan diseases market estimates and forecasts for online sales channel, 2016 - 2030 (USD Million)
  • Fig. 37 Medical foods for orphan diseases market estimates and forecasts for retail sales channel, 2016 - 2030 (USD Million)
  • Fig. 38 Medical foods for orphan diseases market estimates and forecasts for institutional sales channel, 2016 - 2030 (USD Million)
  • Fig. 39 Regional market snapshot, 2022 & 2030, (USD Million)
  • Fig. 40 Medical foods for orphan diseases market: Regional market share analysis, 2022
  • Fig. 41 North America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 42 Europe medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 43 Asia Pacific medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 44 Latin America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 45 MEA medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 46 North America market share, by country, 2016 - 2030 (USD Million)
  • Fig. 47 U.S. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 48 Canada medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 49 Europe market share, by country, 2016 - 2030 (USD Million)
  • Fig. 50 U.K. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 51 Germany medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 52 France medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 53 Spain medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 54 Italy medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 55 Russia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market share, by country, 2016 - 2030 (USD Million)
  • Fig. 57 Japan medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 58 China medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 59 Australia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 60 New Zealand medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 61 India medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 62 South Korea medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 63 Singapore medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 64 Latin America market share, by country, 2016 - 2030 (USD Million)
  • Fig. 65 Brazil medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 66 Mexico medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 67 Argentina medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 68 MEA market share, by country, 2016 - 2030 (USD Million)
  • Fig. 69 South Africa medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 71 UAE medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)